GlaxoSmithKline UK respondsBMJ 2010; 340 doi: http://dx.doi.org/10.1136/bmj.c3464 (Published 29 June 2010) Cite this as: BMJ 2010;340:c3464
- Pim Kon, medical director1
- 1GlaxoSmithKline UK, Uxbridge UB11 1BT
Cohen and Carter explore whether the World Health Organization should have taken advice from experts who had declarable financial and research ties with pharmaceutical companies producing antivirals and influenza vaccines, including GlaxoSmithKline (GSK).1 Can experts provide advice on public health issues such as pandemic flu, as well as help to develop medicines and vaccines for …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial